NORIS, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 5.699
AS - Asia 4.554
EU - Europa 3.925
SA - Sud America 525
AF - Africa 62
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 10
Totale 14.793
Nazione #
US - Stati Uniti d'America 5.574
CN - Cina 2.644
IE - Irlanda 961
SG - Singapore 903
HK - Hong Kong 516
FI - Finlandia 511
UA - Ucraina 479
DE - Germania 478
BR - Brasile 431
RU - Federazione Russa 390
IT - Italia 359
SE - Svezia 305
GB - Regno Unito 185
VN - Vietnam 184
CA - Canada 79
IN - India 79
FR - Francia 73
AR - Argentina 46
BD - Bangladesh 37
IQ - Iraq 32
JP - Giappone 28
MX - Messico 26
PL - Polonia 25
TR - Turchia 23
NL - Olanda 21
ES - Italia 20
ZA - Sudafrica 20
BE - Belgio 18
EC - Ecuador 18
AU - Australia 17
RO - Romania 16
CZ - Repubblica Ceca 15
ID - Indonesia 15
AT - Austria 12
IR - Iran 11
MA - Marocco 10
PK - Pakistan 10
EU - Europa 9
GR - Grecia 9
SA - Arabia Saudita 9
UZ - Uzbekistan 9
CH - Svizzera 8
PY - Paraguay 8
AZ - Azerbaigian 7
CO - Colombia 7
EG - Egitto 7
LT - Lituania 7
AL - Albania 6
JO - Giordania 6
KE - Kenya 5
MU - Mauritius 5
AE - Emirati Arabi Uniti 4
CL - Cile 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
KG - Kirghizistan 4
KR - Corea 4
NP - Nepal 4
VE - Venezuela 4
HN - Honduras 3
HU - Ungheria 3
IL - Israele 3
LU - Lussemburgo 3
PA - Panama 3
PE - Perù 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
TN - Tunisia 3
UY - Uruguay 3
BH - Bahrain 2
CG - Congo 2
CR - Costa Rica 2
DK - Danimarca 2
DM - Dominica 2
EE - Estonia 2
GE - Georgia 2
JM - Giamaica 2
KZ - Kazakistan 2
LB - Libano 2
LV - Lettonia 2
MD - Moldavia 2
NO - Norvegia 2
PH - Filippine 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TM - Turkmenistan 2
AO - Angola 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
ET - Etiopia 1
GH - Ghana 1
GM - Gambi 1
HR - Croazia 1
HT - Haiti 1
KH - Cambogia 1
Totale 14.783
Città #
Dublin 961
Chandler 874
Jacksonville 661
Nanjing 615
Dallas 516
Hong Kong 514
Ashburn 462
Singapore 421
Beijing 409
Boardman 279
Nanchang 224
Princeton 194
Shenyang 184
Wilmington 181
Lawrence 180
Medford 177
Munich 176
Changsha 165
Hebei 165
Helsinki 153
Los Angeles 136
Jiaxing 128
Tianjin 96
Hangzhou 91
Ann Arbor 89
New York 88
Milan 81
Buffalo 73
Ho Chi Minh City 69
Pavia 65
Shanghai 63
Moscow 56
Redondo Beach 53
São Paulo 51
Hanoi 49
Houston 48
Woodbridge 47
Turku 43
Guangzhou 33
Toronto 32
Verona 32
Fairfield 28
The Dalles 28
Tokyo 26
Norwalk 25
Seattle 25
Brooklyn 24
Council Bluffs 23
Denver 23
Chennai 22
Montreal 22
London 21
Warsaw 21
Orem 20
Santa Clara 20
Pune 19
Zhengzhou 19
San Francisco 18
Belo Horizonte 17
Brasília 17
Brussels 17
Ankara 16
Falkenstein 16
Des Moines 15
Jinan 15
Phoenix 15
Atlanta 14
Chicago 14
Johannesburg 14
Mexico City 14
Rio de Janeiro 14
Stockholm 14
Brno 13
Columbus 13
Manchester 13
Falls Church 12
Timisoara 12
Auburn Hills 11
Rome 11
San Jose 11
Secaucus 11
Nuremberg 10
Baghdad 9
Boston 9
Frankfurt am Main 9
Fuzhou 9
Kunming 9
Mumbai 9
Ningbo 9
Paris 9
Pescara 9
St Petersburg 9
Sydney 9
Taizhou 9
Tashkent 9
Curitiba 8
Palermo 8
Salvador 8
Baku 7
Dhaka 7
Totale 9.802
Nome #
Anemia in patients with Covid-19: pathogenesis and clinical significance 255
Personalized reference intervals for platelet count reduce the number of subjects with unexplained thrombocytopenia 149
Abdominal lymphographic pattern in connective tissue diseases is quite similar to that observed in lymphocytic lymphoma. 145
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 141
Antigeni minori di istocompatibilità 136
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 130
Correction to: Anemia in patients with Covid-19: pathogenesis and clinical significance (Clinical and Experimental Medicine, (2021), 10.1007/s10238-020-00679-4) 130
Correction to: Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy (Internal and Emergency Medicine, (2021), 16, 5, (1141-1152), 10.1007/s11739-020-02550-6) 128
A new variant of Bernard-Soulier syndrome characterized by dysfunctional glycoprotein (GP) IB and severely reduced amounts of GPIX and GPV. 127
NOVEL PERSPECTIVES IN GENOTYPE-PHENOTYPE CORRELATIONS IN MYH9-RELATED DISEASE: NO LONGER JUST A MATTER OF HEAD OR TAIL 126
Clinical and pathogenetic characterization of ETV6-related thrombocytopenia (ETV6-RT), an inherited thrombocytopenia (IT) predisposing to childhood acute lymphoblastic leukemia (ALL) 122
Altered cytoskeleton organization in platelets from patients with MYH9-related disease. 117
Analysis of 65 pregnancies in 34 women with five different forms of inherited platelet function disorders 115
A Leu40Pro substitution in the leucine rich motif (LRM) of glycoprotein (GP) IX is responsible for dysfunction of a normally expressed GPIB alpha in Bernard-Soulier syndrome (BSS) 114
Impact of COVID-19 on liver function: results from an internal medicine unit in Northern Italy 114
ACTN1-related thrombocytopenia: identification of novel families for phenotypic characterization. 111
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 110
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 109
Immunocytochemistry for the heavy chain of the non-muscle myosin IIA as a diagnostic tool for MYH9-related disorders. 108
A HOMOZYGOUS POINT MUTATION IN A LEUCINE-RICH MOTIF OF PLATELET GLYCOPROTEIN-IX ASSOCIATED WITH BERNARD-SOULIER SYNDROME (BSS) 107
Spectrum of the mutations in Bernard-Soulier syndrome. 106
Autosomal dominant thrombocytopenias with reduced expression of glycoprotein Ia 106
Venous thromboembolism and COVID-19: a single center experience from an academic tertiary referral hospital of Northern Italy 106
Confronto di due metodi di criopreservazione piastrinica basati sull'impiego di glicerolo-glucosio o DMSO: studio della funzionalità piastrinica in vitro. 105
Ubiquitin/proteasome-rich particulate cytoplasmic structures (PaCSs) in the platelets and megakaryocytes of ANKRD26-related thrombo-cytopenia. 105
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 105
Absence of CYCS mutations in a large Italian cohort of patients with inherited thrombocytopenias of unknown origin. 103
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 103
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 103
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders. 102
Heparin modifies platelet count and function in patients who have undergone thrombolytic therapy for acute myocardial infarction. 102
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 102
Clinical and genetic aspects Bernard-Soulier syndrome: searching for genotype/phenotype correlations. 101
A phenylalanine-55 to serine amino-acid substitution in the human glycoprotein IX leucine-rich repeat is associated with Bernard-Soulier syndrome. 100
Inherited thrombocytopenias. The evolving spectrum. 100
IN VIVO AND IN VITRO EFFECTS OF THROMBOLYTIC AGENTS ON PLATELET COMPOSITION AND FUNCTION 99
Particulate cytoplasmic structures with high concentration of ubiquitin-proteasome accumulate in myeloid neoplasms 98
A new form of inherited thrombocytopenia due to monoallelic loss of function mutation in the thrombopoietin gene 98
Thrombocytopenia, giant platelets, and leukocyte inclusion bodies (May-Hegglin anomaly). Clinical and laboratory findings. 97
Alteration of Liver Enzymes Is a Feature of the Myh9-Related Disease Syndrome. 97
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function. 96
MYH9-related disease: five novel mutations expanding the spectrum of causative mutations and confirming genotype/phenotype correlations. 95
Clinical and laboratory features of 103 patients from 42 Italian families with inherited thrombocytopenia derived from the monoallelic Ala156Val mutation of GPIb{alpha} (Bolzano mutation). 95
Cryopreservation of human platelets using dimethyl sulfoxide and glycerol-glucose: effects on "in vitro" platelet function. 94
A MONOALLELIC LOSS-FUNCTION MUTATION IN THE THROMBOPOIETIN (THPO) GENE IS RESPONSIBLE FOR A NEW FORM OF INHERITED THROMBOCYTOPENIA (IT) 94
Autoimmunità e piastrinopatie [Autoimmunity and platelet disorders] 93
Autologous cryopreserved platelets can efficiently support patients with breast cancer after high-dose chemotherapy and circulating progenitor cell transplantation 93
NITROGLYCERIN INFUSION - HEMODYNAMIC AND ANTI-PLATELETS EFFECTS IN PATIENTS WITH CARDIOMYOPATHY 93
A novel mutation in gp1bb reveals the role of the cytoplasmic domain of gpibβ in the pathophysiology of bernard‐soulier syndrome and gpib‐ix complex assembly 93
Thrombopoietin is not uniquely responsible for thrombocytosis in inflammatory disorders 92
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 92
Autologous transfusion of thrombosol plus low-dose DMSO cryopreserved platelet concentrates (PCs) for severe thrombocytopenia following high-dose chemotherapy (HDC). 92
Defect of platelet aggregation and adhesion induced by autoantibody against glycoprotein IIIa. 91
β-1 tubulin R307H SNP alters microtubule dynamics and affects severity of a hereditary thrombocytopenia. 91
Platelet-independent defect in hemostasis associated with sirolimus use 90
Both haploinsufficiency and dominant negative effects are responsible for abnormalities of patiens with MHY9-related disease. 90
Heparin infusion facilitates ex vivo platelet aggregation in patients with acute myocardial infarction who have undergone thrombolytic therapy. 90
Application of a diagnostic algorithm to 50 consecutive patients with inherited thrombocytopenias 89
Platelet predeposit and transfusion in patients receiving high-dose chemotherapy and autologous transplant for breast cancer 88
Platelet function after 'in vivo' and 'in vitro' treatment with thrombolytic agents. 88
NEONATAL ALLOIMMUNE THROMBOCYTOPENIA (NATP) CAUSED BY A NEW LOW-FREQUENCY PLATELET-SPECIFIC ALLOANTIGEN, MAXA, LOCATED ON GPIIB 87
X-linked thrombocytopenia with thalassemia: Clinical and biological features of a second family 87
Donor-recipient incompatibility at CD31-codon 563 is a major risk factor for acute graft-versus-host disease after allogeneic bone marrow transplantation from a human leucocyte antigen-matched donor. 86
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk disorders. In patients the SPATA-DVT with inherited Study platelet 86
Platelet composition and function in patients undergoing cardiopulmonary bypass for hearth surgery. 85
Effect of 52 monoclonal antibodies against platelet membrane on platelet aggregation and release reaction 85
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 85
Application of a diagnostic algorithm for inherited thrombocytopenias to 46 consecutive patients. 84
Splenectomia in corso di porpora trombocitopenica idiopatica: fattori prognostici e risultati clinici. 84
Inherited thrombocytopenias in the era of personalized medicine 83
Eltrombopag for the treatment of inherited thrombocytopenias: A phase II clinical trial 83
The effect of red blood cells on platelet aggregation; a study with the whole blood aggregometer 82
High versus standard dose methylprednisolone in the acute phase of idiopathic thrombotic thrombocytopenic purpura: a randomized study. 82
NOVEL RUNX1 MUTATIONS IN FAMILIES WITH INHERITED THROMBOCYTOPENIA 82
In vitro and in vivo effects of desmopressin on platelet function 82
Transfusion of platelet concentrates cryopreserved with thromboSol plus low-dose dimethilsulphoxide in patients with severe thrombocytopenia: a pilot study 81
Malattia di von Willebrand tipo IIb: descrizione di un caso clinico 81
CYCLIC THROMBOCYTOPENIA-THROMBOCYTOSIS WITH A PERIODIC DEFECT OF PLATELET-FUNCTION - REPORT OF A CASE 81
Genetics, clinical and pathological features of glomerulonephritis associated with mutations of nonmuscle myosin IIA (Fechtner syndrome) 81
Effect of anagrelide on platelet count and function in patients with thrombocytosis and myeloproliferative disorders. 81
Dysregulation of oncogenic factors by GFI1B p32: investigation of a novel GFI1B germline mutation 81
Thrombopoietin levels in patients with primary and reactive thrombocytosis. 79
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 79
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 79
ANKRD26-related thrombocytopenia and myeloid malignancies 79
Clinical and pathogenic features of ETV6-related thrombocytopenia with predisposition to acute lymphoblastic leukemia 79
Application of a Diagnostic Algorithm for Inherited Thrombocytopenia Patients in the Setting of a Developing Country. 78
Exome sequencing in 116 patients with inherited thrombocytopenia that remained of unknown origin after systematic phenotype-driven diagnostic workup 77
Haemophagocytic syndrome responding to high-dose gamma-globulin as presenting feature of sarcoidosis. 77
MYH9-related disease: a novel prognostic model to predict the clinical evolution of the disease based on genotype-phenotype correlations. 77
A review of platelet secretion assays for the diagnosis of inherited platelet secretion disorders 77
Platelet count and aging 76
Incompatibility at CD31, HPA3 or HPA5 loci are HLA-A2-restricted risk factors for acute GVHD. 76
May-Hegglin anomaly: Clinical and laboratory investigation of 14 cases 76
Desmopressin and platelets: In vitro and in vivo studies 76
Mutations Identified in Thrombocytopenia THC2 Are Likely to Dysregulate ANKRD26 Expression. 76
MYH9-related thrombocytopenia and intracranial bleedings: A complex clinical/surgical management and review of the literature 76
New roles for mean platelet volume measurement in the clinical practice? 76
ACTN1 mutations lead to a benign form of platelet macrocytosis not always associated with thrombocytopenia 76
Factors influencing post-transfusional platelet increment in pediatric patients given hematopoietic stem cell transplantation. 75
Totale 9.684
Categoria #
all - tutte 67.845
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.845


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021693 0 0 0 0 0 123 8 156 80 152 138 36
2021/2022913 24 1 32 17 36 48 14 53 53 35 108 492
2022/20232.615 273 158 15 232 265 271 5 138 1.122 21 67 48
2023/2024890 113 125 33 82 107 240 19 58 11 39 37 26
2024/20252.556 48 230 53 84 52 178 141 201 534 89 321 625
2025/20263.476 499 432 827 731 716 271 0 0 0 0 0 0
Totale 15.220